Chandler Redonna, Gordon Michael S, Kruszka Bridget, Strand Lauren N, Altice Frederick L, Beckwith Curt G, Biggs Mary L, Cunningham William, Chris Delaney J A, Flynn Patrick M, Golin Carol E, Knight Kevin, Kral Alex H, Kuo Irene, Lorvick Jennifer, Nance Robin M, Ouellet Lawrence J, Rich Josiah D, Sacks Stanley, Seal David, Spaulding Anne, Springer Sandra A, Taxman Faye, Wohl David, Young Jeremy D, Young Rebekah, Crane Heidi M
Division of Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Washington, DC, USA.
Friends Research Institute, Baltimore, MD, USA.
Subst Abuse Treat Prev Policy. 2017 May 16;12(1):24. doi: 10.1186/s13011-017-0107-4.
The STTR treatment cascade provides a framework for research aimed at improving the delivery of services, care and outcomes of PLWH. The development of effective approaches to increase HIV diagnoses and engage PLWH in subsequent steps of the treatment cascade could lead to earlier and sustained ART treatment resulting in viral suppression. There is an unmet need for research applying the treatment cascade to improve outcomes for those with criminal justice involvement.
The Seek, Test, Treat, and Retain (STTR) criminal justice (CJ) cohort combines data from 11 studies across the HIV treatment cascade that focused on persons involved in the criminal justice system, often but not exclusively for reasons related to substance use. The studies were conducted in a variety of CJ settings and collected information across 11 pre-selected domains: demographic characteristics, CJ involvement, HIV risk behaviors, HIV and/or Hepatitis C infections, laboratory measures of CD4 T-cell count (CD4) and HIV RNA viral load (VL), mental illness, health related quality of life (QoL), socioeconomic status, health care access, substance use, and social support.
The STTR CJ cohort includes data on 11,070 individuals with and without HIV infection who range in age from 18 to 77 years, with a median age at baseline of 37 years. The cohort reflects racial, ethnic and gender distributions in the U.S. CJ system, and 64% of participants are African-American, 12% are Hispanic and 83% are men. Cohort members reported a wide range of HIV risk behaviors including history of injection drug use and, among those who reported on pre-incarceration sexual behaviors, the prevalence of unprotected sexual intercourse ranged across studies from 4% to 79%. Across all studies, 53% percent of the STTR CJ cohort reported recent polysubstance use.
The STTR CJ cohort is comprised of participants from a wide range of CJ settings including jail, prison, and community supervision who report considerable diversity in their characteristics and behavioral practices. We have developed harmonized measures, where feasible, to improve the integration of these studies together to answer questions that cannot otherwise be addressed.
STTR治疗级联为旨在改善艾滋病毒感染者的服务提供、护理和治疗结果的研究提供了一个框架。开发有效的方法来增加艾滋病毒诊断,并使艾滋病毒感染者参与治疗级联的后续步骤,可能会导致更早和持续的抗逆转录病毒治疗,从而实现病毒抑制。对于应用治疗级联来改善有刑事司法介入者的治疗结果的研究,仍存在未满足的需求。
寻求、检测、治疗和保留(STTR)刑事司法(CJ)队列结合了来自11项艾滋病毒治疗级联研究的数据,这些研究聚焦于刑事司法系统中的人员,通常但不限于与物质使用相关的原因。这些研究在各种刑事司法环境中进行,并收集了11个预先选定领域的信息:人口统计学特征、刑事司法介入情况、艾滋病毒风险行为、艾滋病毒和/或丙型肝炎感染、CD4 T细胞计数(CD4)和艾滋病毒RNA病毒载量(VL)的实验室检测指标、精神疾病、健康相关生活质量(QoL)、社会经济地位、医疗保健可及性、物质使用情况以及社会支持。
STTR CJ队列包括11070名有或没有艾滋病毒感染的个体的数据,年龄在18至77岁之间,基线时的中位年龄为37岁。该队列反映了美国刑事司法系统中的种族、族裔和性别分布情况,64%的参与者是非裔美国人,12%是西班牙裔,83%是男性。队列成员报告了广泛的艾滋病毒风险行为,包括注射吸毒史,在那些报告入狱前性行为的人中,无保护性行为的患病率在不同研究中从4%到79%不等。在所有研究中,53%的STTR CJ队列报告近期使用多种物质。
STTR CJ队列由来自各种刑事司法环境(包括监狱、监禁场所和社区监管)的参与者组成,他们在特征和行为习惯方面表现出相当大的差异。我们已在可行的情况下制定了统一的测量方法,以改善这些研究的整合,从而回答那些无法通过其他方式解决的问题。